| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.2M | -17.4% |
| Cost of Revenue | $4.4M | -15.5% |
| Gross Profit | $6.8M | -18.5% |
| R&D Expense | $2.5M | +0.6% |
| SG&A Expense | $14.1M | +53.8% |
| Operating Income | -$46.4M | +18.0% |
| Pre-tax Income | -$46.6M | +24.9% |
| Income Tax | -$380K | -258.5% |
| Net Income | -$46.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.9M | -83.1% |
| Accounts Receivable | $2.2M | -22.6% |
| Inventory | $3.6M | +20.2% |
| Current Assets | $9.9M | -67.2% |
| Total Assets | $11.1M | -79.5% |
| Current Liabilities | $7.5M | +2.0% |
| Total Liabilities | $7.5M | -8.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.9M | -42.5% |
| Investing Cash Flow | -$92K | -105.0% |
| Financing Cash Flow | $3.1M | -90.6% |
| +25.4% |
| EPS (Basic) | -$108.90 | -2078.0% |
| EPS (Diluted) | -$108.90 | -2078.0% |
| Stockholders' Equity |
| $3.7M |
| -92.1% |